Alzheimer's Disease

Showing 26 - 50 of 955

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer's Disease Trial in Kansas City (Creatine Monohydrate)

Recruiting
  • Alzheimer's Disease
  • Creatine Monohydrate
  • Kansas City, Kansas
    University of Kansas Medical Center
Jan 9, 2023

Tau PET/CT Imaging in Mismatch Prospective Cohort Study

Recruiting
  • Alzheimer's Disease
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 6, 2023

Alzheimer's Disease Trial in Heidelberg, Shepparton, West Perth (SLS-005, Placebo)

Not yet recruiting
  • Alzheimer's Disease
  • Heidelberg, Victoria, Australia
  • +2 more
Dec 23, 2022

Alzheimer's Disease, Mild Cognitive Impairment Trial in Irvine, Los Angeles (Nicotinamide, Placebo Comparator)

Completed
  • Alzheimer's Disease
  • Mild Cognitive Impairment
  • Irvine, California
  • +1 more
Dec 14, 2022

Alzheimer's Disease Trial in United States (Hydroxypropyl Beta Cyclodextrin, Placebo)

Recruiting
  • Alzheimer's Disease
  • Hydroxypropyl Beta Cyclodextrin
  • Placebo
  • Brooksville, Florida
  • +4 more
Nov 22, 2022

Alzheimer's Disease Trial in Colombia (Crenezumab, Placebo)

Active, not recruiting
  • Alzheimer's Disease
  • Armenia, Colombia
  • +3 more
Nov 21, 2022

Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis

Recruiting
  • Alzheimer's Disease
    • Beijing, Beijing, China
      Xuanwu Hospital of Capital Medical University
    Nov 15, 2022

    Alzheimer's Disease Trial in San Antonio (PU-AD, Placebo)

    Completed
    • Alzheimer's Disease
    • San Antonio, Texas
      ICON Early Phase Services
    Nov 14, 2022

    Alzheimer's Disease Trial in Worldwide (BIIB092, Placebo)

    Terminated
    • Alzheimer's Disease
    • Birmingham, Alabama
    • +100 more
    Oct 18, 2022

    Alzheimer's Disease Trial in Worldwide (PF-04360365 0.1 mg/kg, PF-04360365 0.5 mg/kg, PF-04360365 1 mg/kg)

    Completed
    • Alzheimer's Disease
    • PF-04360365 0.1 mg/kg
    • +5 more
    • Peoria, Arizona
    • +41 more
    Oct 11, 2022

    Mild Cognitive Impairment, Alzheimer's Disease Trial in New York (Lighting Intervention Therapy, Sham LIT)

    Recruiting
    • Mild Cognitive Impairment
    • Alzheimer's Disease
    • Lighting Intervention Therapy
    • Sham LIT
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Oct 25, 2022

    BEAM: Brain-Eye Amyloid Memory Study

    Recruiting
    • Alzheimer's Disease
    • +4 more
    • Pittsburgh Compound B [11C]-PIB
    • Toronto, Ontario, Canada
    • +4 more
    Oct 24, 2022

    Mild Cognitive Impairment, Alzheimer's Disease Trial (Centella asiatica product, Placebo)

    Not yet recruiting
    • Mild Cognitive Impairment
    • Alzheimer's Disease
    • Centella asiatica product
    • Placebo
    • (no location specified)
    Oct 18, 2022

    Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)

    Active, not recruiting
    • Alzheimer's Disease
    • Garden Grove, California
    • +48 more
    Sep 1, 2022

    Alzheimer's Disease, Dementia With Lewy Bodies, Frontotemporal Dementia Trial in Rochester (Pittsburgh Compound B (C-11 PiB),

    Enrolling by invitation
    • Alzheimer's Disease
    • +3 more
    • Pittsburgh Compound B (C-11 PiB)
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic
    Sep 30, 2022

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia,

    Recruiting
    • Alzheimer's Disease
    • +2 more
    • DaTscan
    • +5 more
    • Columbus, Ohio
      The Ohio State University
    Sep 23, 2022

    Alzheimer's Disease Trial in Israel, United Kingdom (IBC-Ab002, Placebo)

    Not yet recruiting
    • Alzheimer's Disease
    • IBC-Ab002
    • Placebo
    • Haifa, Israel
    • +5 more
    Sep 20, 2022

    Alzheimer's Disease, Mild Cognitive Impairment Due to Alzheimer's Disease, Healthy Volunteers Trial in Wuhan ([18F]APN-1607)

    Recruiting
    • Alzheimer's Disease
    • +2 more
    • Wuhan, Hubei, China
      Union Hospital Tongji Medical College Huazhong University of Sci
    Sep 13, 2022

    Alzheimer's Disease Trial in Baton Rouge (Healthy Lifestyle Program, Physical Activity Intervention)

    Completed
    • Alzheimer's Disease
    • Healthy Lifestyle Program
    • Physical Activity Intervention
    • Baton Rouge, Louisiana
    • +1 more
    Sep 13, 2022

    Longitudinal Quantitative Susceptibility Mapping in Alzheimer 's

    Enrolling by invitation
    • Alzheimer's Disease
    • MRI
    • (no location specified)
    Aug 24, 2022

    Alzheimer's Disease Trial in Worldwide (Placebo, Bepranemab)

    Recruiting
    • Alzheimer's Disease
    • Placebo
    • Bepranemab
    • Sun City, Arizona
    • +115 more
    Aug 18, 2022

    Alzheimer's Disease Trial in United States (Remternetug (IV), Remternetug (SC), Placebo)

    Recruiting
    • Alzheimer's Disease
    • Remternetug (IV)
    • +2 more
    • Chandler, Arizona
    • +70 more
    Aug 10, 2022

    Alzheimer's Disease Trial in United States (Aducanumab, Placebo)

    Recruiting
    • Alzheimer's Disease
    • Santa Ana, California
    • +19 more
    Aug 9, 2022

    Alzheimer's Disease Trial in United States (Posiphen, Placebo)

    Active, not recruiting
    • Alzheimer's Disease
    • La Jolla, California
    • +5 more
    Aug 1, 2022

    Alzheimer's Disease Trial (TB006)

    Not yet recruiting
    • Alzheimer's Disease
    • (no location specified)
    Jul 25, 2022